171 related articles for article (PubMed ID: 37323162)
1. Implications of gender-affirming endocrine care for sports participation.
Moreland E; Cheung AS; Hiam D; Nolan BJ; Landen S; Jacques M; Eynon N; Jones P
Ther Adv Endocrinol Metab; 2023; 14():20420188231178373. PubMed ID: 37323162
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Gender-Affirming Hormone Therapy on Physical Performance.
Cheung AS; Zwickl S; Miller K; Nolan BJ; Wong AFQ; Jones P; Eynon N
J Clin Endocrinol Metab; 2024 Jan; 109(2):e455-e465. PubMed ID: 37437247
[TBL] [Abstract][Full Text] [Related]
4. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract][Full Text] [Related]
5. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
[TBL] [Abstract][Full Text] [Related]
6. Transgender health and the impact of aging and menopause.
Cheung AS; Nolan BJ; Zwickl S
Climacteric; 2023 Jun; 26(3):256-262. PubMed ID: 37011669
[TBL] [Abstract][Full Text] [Related]
7. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
[TBL] [Abstract][Full Text] [Related]
8. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
[TBL] [Abstract][Full Text] [Related]
9. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
Suppakitjanusant P; Ji Y; Stevenson MO; Chantrapanichkul P; Sineath RC; Goodman M; Alvarez JA; Tangpricha V
J Clin Transl Endocrinol; 2020 Sep; 21():100230. PubMed ID: 32685379
[TBL] [Abstract][Full Text] [Related]
10. Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons.
Morssinkhof MWL; Wiepjes CM; Bosman BW; Kinds J; Fisher AD; Greenman Y; Kreukels BPC; T'Sjoen G; van der Werf YD; Heijer MD; Broekman BFP
Sleep Med; 2023 Jul; 107():316-326. PubMed ID: 37271109
[TBL] [Abstract][Full Text] [Related]
11. Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature.
Tang GT; Zwickl S; Sinclair R; Zajac JD; Cheung AS
Clin Exp Dermatol; 2023 Sep; 48(10):1117-1127. PubMed ID: 37311161
[TBL] [Abstract][Full Text] [Related]
12. Fit Transitioning: When Can Transgender Airmen Fitness Test in Their Affirmed Gender?
Chiccarelli E; Aden J; Ahrendt D; Smalley J
Mil Med; 2023 Jul; 188(7-8):e1588-e1595. PubMed ID: 36271916
[TBL] [Abstract][Full Text] [Related]
13. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
Zaliznyak M; Jung EE; Bresee C; Garcia MM
J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
[TBL] [Abstract][Full Text] [Related]
14. The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand.
Ittiphisit S; Amponnavarat S; Manaboriboon N; Korpaisarn S
Sex Med; 2022 Jun; 10(3):100513. PubMed ID: 35428019
[TBL] [Abstract][Full Text] [Related]
15. A Proposed Inventory to Assess Changes in Orgasm Function of Transgender Patients Following Gender Affirming Treatments: Pilot Study.
Zaliznyak M; Lauzon M; Stelmar J; Yuan N; Smith SM; Garcia MM
Sex Med; 2022 Jun; 10(3):100510. PubMed ID: 35472753
[TBL] [Abstract][Full Text] [Related]
16. Gender-Affirming Hormone Therapy: Physical and Sociopsychological Effects, Impact and Satisfaction.
Santos RB; Lemos C; Saraiva M
Cureus; 2023 Mar; 15(3):e36484. PubMed ID: 37090416
[TBL] [Abstract][Full Text] [Related]
17. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
[TBL] [Abstract][Full Text] [Related]
19. Gender-affirming pharmacotherapy and additional health considerations: A contemporary review.
Mercer J; Bandy S; Tang H; Wenger B; Ryan L; Lee G; Lipscomb J
J Am Pharm Assoc (2003); 2023; 63(6):1669-1676.e1. PubMed ID: 37619851
[TBL] [Abstract][Full Text] [Related]
20. Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy.
Silva ED; Fighera TM; Allgayer RM; Lobato MIR; Spritzer PM
Front Psychiatry; 2021; 12():621075. PubMed ID: 34381383
[No Abstract] [Full Text] [Related]
[Next] [New Search]